The Daily Digest intends to help readers track major announcements made by and about companies on the San Diego Stock Exchange Index. The Daily Digest tracks announcements and SEC filings released from midnight until 4 p.m., or three hours after the stock markets close. To see how companies on the San Diego Stock Exchange Index performed, visit sddt.com/stocks.
Acadia Pharmaceuticals Inc.: Company announced it is hosting a conference call and webcast to discuss its top-line results from its Phase III trial with pimavanserin in patients with Parkinsonís disease psychosis.
AMN Healthcare Services Inc.: SEC documents showed Vice President Denise Jackson exercised options on 7,500 shares at $9.68 per share, and sold 7,284 shares at $10.75 per share on Nov. 21.
Digirad Corp.: SEC documents showed: Director Charles Gillman purchased 15,000 shares at $2.02 to $2.08 per share between Nov. 21-26; and Director Jeffrey Eberwein purchased 15,000 shares at $2.02 to $2.08 per share between Nov. 21-26.
Illumina Inc.: Company was downgraded to “neutral” from “outperform” by brokerage firm Robert W. Baird & Co.
Inovio Pharmaceuticals Inc.: Company announced that testing of multiple synthetic vaccine constructs for cytomegalovirus induced robust T cells in mice.
Life Technologies Corp.: SEC documents showed Chairman of the Board Gregory Lucier exercised options on 161,942 shares at $0 per share, and surrendered 75,595 shares at $49.22 per share on Nov. 21.